methylnitrosourea has been researched along with erucylphospho-n,n,n-trimethylpropylammonium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, MR; Dineva, IK; Eibl, H; Konstantinov, SM; Zaharieva, MM | 1 |
1 other study(ies) available for methylnitrosourea and erucylphospho-n,n,n-trimethylpropylammonium
| Article | Year |
|---|---|
Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Class Ia Phosphatidylinositol 3-Kinase; Dose-Response Relationship, Drug; Female; Humans; Immunoblotting; Mammary Neoplasms, Experimental; MCF-7 Cells; Methylnitrosourea; Mitogen-Activated Protein Kinases; Molecular Structure; Organophosphates; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Quaternary Ammonium Compounds; ras Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Burden; Weight Loss | 2012 |